Maze Therapeutics, Inc.
Biotechnology company · South San Francisco, California, United States · Nasdaq: MAZE
Maze Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its shares trade on Nasdaq under the ticker MAZE.
Profile compiled from public records. Is this your company? Request a correction or update
Maze Therapeutics at a glance
Typebiotechnology company
HeadquartersSouth San Francisco, California, United States
Stock listingNasdaq: MAZE
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1842295
Frequently asked questions about Maze Therapeutics
Where is Maze Therapeutics headquartered?
Maze Therapeutics, Inc. is headquartered in South San Francisco, California, United States.
What does Maze Therapeutics do?
Maze Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Maze Therapeutics a public company?
Yes. Maze Therapeutics, Inc. trades on Nasdaq under the ticker MAZE.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences